SCHEMBL6406549

SCHEMBL6406549

COC(=O)c1ccc(CSc2nnc(-c3cccs3)[nH]2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.51
NPC1 O15118 6/20 0.51
RAB9A P51151 6/20 0.51
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
LMNA P02545 2/20 0.51
HPGD P15428 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TP53 P04637 3/20 0.46
MMP13 P45452 2/20 0.46
POLB P06746 2/20 0.45
OPRK1 P41145 1/20 0.45
GAA P10253 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
TSHR P16473 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404560 0.86 HPGD (0.51) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6409758 0.79 SMN1; SMN2 (0.56) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6403770 0.79 SMN1; SMN2 (0.44) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6406951 0.78 NPC1 (0.57) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6406023 0.77 NPC1 (0.47) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL15986413 0.77 ALDH1A1 (0.62) MAPTRAB9AALDH1A1TP53POLB
SCHEMBL16171148 0.75 MEN1 (0.54) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4200700 0.74 MAPT (0.72) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6406156 0.74 GRK6 (0.59) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6408378 0.72 LMNA (0.48) MAPTNPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MAPT 2111/4885NPC1 2070/4885RAB9A 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.